{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:17:12Z","timestamp":1791037032399,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,4,3]],"date-time":"2009-04-03T00:00:00Z","timestamp":1238716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s10552-009-9331-1","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T15:19:54Z","timestamp":1238685594000},"page":"1071-1082","source":"Crossref","is-referenced-by-count":246,"title":["The epidemiology of triple-negative breast cancer, including race"],"prefix":"10.1007","volume":"20","author":[{"given":"Katrina F.","family":"Trivers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jo","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy L.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Liff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine W.","family":"Flagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph J.","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. William","family":"Eley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,3]]},"reference":[{"key":"9331_CR1","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98:10869\u201310874. doi: 10.1073\/pnas.191367098","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9331_CR2","doi-asserted-by":"crossref","first-page":"10393","DOI":"10.1073\/pnas.1732912100","volume":"100","author":"C Sotiriou","year":"2003","unstructured":"Sotiriou C, Neo SY, McShane LM et al (2003) Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 100:10393\u201310398. doi: 10.1073\/pnas.1732912100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9331_CR3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2164-7-127","volume":"7","author":"T Sorlie","year":"2006","unstructured":"Sorlie T, Wang Y, Xiao C et al (2006) Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics 7:127. doi: 10.1186\/1471-2164-7-127","journal-title":"BMC Genomics"},{"key":"9331_CR4","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 295:2492\u20132502. doi: 10.1001\/jama.295.21.2492","journal-title":"JAMA"},{"key":"9331_CR5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747\u2013752. doi: 10.1038\/35021093","journal-title":"Nature"},{"key":"9331_CR6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/jnci\/djj052","volume":"98","author":"C Sotiriou","year":"2006","unstructured":"Sotiriou C, Wirapati P, Loi S et al (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98:262\u2013272","journal-title":"J Natl Cancer Inst"},{"key":"9331_CR7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1158\/1055-9965.EPI-06-0806","volume":"16","author":"XR Yang","year":"2007","unstructured":"Yang XR, Sherman ME, Rimm DL et al (2007) Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 16:439\u2013443. doi: 10.1158\/1055-9965.EPI-06-0806","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9331_CR8","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/j.ejca.2006.08.015","volume":"42","author":"EA Rakha","year":"2006","unstructured":"Rakha EA, El-Rehim DA, Paish C et al (2006) Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance. Eur J Cancer 42:3149\u20133156. doi: 10.1016\/j.ejca.2006.08.015","journal-title":"Eur J Cancer"},{"key":"9331_CR9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.22381","volume":"109","author":"EA Rakha","year":"2007","unstructured":"Rakha EA, El-Sayed ME, Green AR, Lee AHS, Robertson JF, Ellis IO (2007) Prognostic markers in triple-negative breast cancer. Cancer 109:25\u201332. doi: 10.1002\/cncr.22381","journal-title":"Cancer"},{"key":"9331_CR10","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.ejca.2004.08.021","volume":"40","author":"T Sorlie","year":"2004","unstructured":"Sorlie T (2004) Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur J Cancer 40:2667\u20132675. doi: 10.1016\/j.ejca.2004.08.021","journal-title":"Eur J Cancer"},{"key":"9331_CR11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ijc.23518","volume":"123","author":"F Bertucci","year":"2008","unstructured":"Bertucci F, Finetti P, Cervera N et al (2008) How basal are triple-negative breast cancers? Int J Cancer 123:236\u2013240. doi: 10.1002\/ijc.23518","journal-title":"Int J Cancer"},{"key":"9331_CR12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10549-008-9926-3","volume":"113","author":"MJ Lund","year":"2009","unstructured":"Lund MJ, Trivers KF, Porter PL et al (2009) Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat 113:357\u2013370. doi: 10.1007\/s10549-008-9926-3","journal-title":"Breast Cancer Res Treat"},{"key":"9331_CR13","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.22618","volume":"109","author":"KR Bauer","year":"2007","unstructured":"Bauer KR, Brown M, Cress RD, Parise CR, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer 109:1721\u20131728. doi: 10.1002\/cncr.22618","journal-title":"Cancer"},{"key":"9331_CR14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10549-007-9632-6","volume":"109","author":"RC Millikan","year":"2008","unstructured":"Millikan RC, Newman B, Tse CK et al (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109:123\u2013139. doi: 10.1007\/s10549-007-9632-6","journal-title":"Breast Cancer Res Treat"},{"key":"9331_CR15","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/cncr.22836","volume":"110","author":"GJ Morris","year":"2007","unstructured":"Morris GJ, Naidu S, Topham AK et al (2007) Differences in breast carcinoma characteristics in newly diagnosed African\u2013American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute\u2019s surveillance, epidemiology, and end results database. Cancer 110:876\u2013884. doi: 10.1002\/cncr.22836","journal-title":"Cancer"},{"key":"9331_CR16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10549-007-9560-5","volume":"107","author":"A Stark","year":"2008","unstructured":"Stark A, Kapke A, Schultz D, Brown R, Linden M, Raju U (2008) Advanced stages and poorly differentiated grade are associated with an increased risk of HER2\/neu positive breast carcinoma only in white women: findings from a prospective cohort study of African\u2013American and white-American women. Breast Cancer Res Treat 107:405\u2013414. doi: 10.1007\/s10549-007-9560-5","journal-title":"Breast Cancer Res Treat"},{"key":"9331_CR17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/cncr.23569","volume":"113","author":"MJ Lund","year":"2008","unstructured":"Lund MJ, Butler EN, Bumpers HL et al (2008) High prevalence of triple-negative tumors in an urban cancer center. Cancer 113:608\u2013615. doi: 10.1002\/cncr.23569","journal-title":"Cancer"},{"key":"9331_CR18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bjc.6604174","volume":"98","author":"RL Bowen","year":"2008","unstructured":"Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL (2008) Early onset of breast cancer in a group of British black women. Br J Cancer 98:277\u2013281. doi: 10.1038\/sj.bjc.6604174","journal-title":"Br J Cancer"},{"key":"9331_CR19","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/cncr.23786","volume":"113","author":"AI Phipps","year":"2008","unstructured":"Phipps AI, Malone KE, Porter PL, Daling JR, Li CI (2008) Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer 113:1521\u20131526. doi: 10.1002\/cncr.23786","journal-title":"Cancer"},{"key":"9331_CR20","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-08-0206","volume":"17","author":"AI Phipps","year":"2008","unstructured":"Phipps AI, Malone KE, Porter PL, Daling JR, Li CI (2008) Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 17:2078\u20132086. doi: 10.1158\/1055-9965.EPI-08-0206","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9331_CR21","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jnci\/87.11.827","volume":"87","author":"LA Brinton","year":"1995","unstructured":"Brinton LA, Daling JR, Liff JM et al (1995) Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 87:827\u2013835. doi: 10.1093\/jnci\/87.11.827","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 2","key":"9331_CR22","first-page":"51S","volume":"6","author":"National Heart Blood Lung Institute (NHLBI) expert panel on the identification, evaluation, treatment of overweight, obesity in adults","year":"1998","unstructured":"National Heart Blood Lung Institute (NHLBI) expert panel on the identification, evaluation, treatment of overweight, obesity in adults (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 6(suppl 2):51S\u2013209S","journal-title":"Obes Res"},{"key":"9331_CR23","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/cncr.20169","volume":"1008","author":"K Gwyn","year":"2004","unstructured":"Gwyn K, Bondy ML, Cohen DS et al (2004) Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 1008:1595\u20131604. doi: 10.1002\/cncr.20169","journal-title":"Cancer"},{"key":"9331_CR24","volume-title":"Manual for staging of cancer","author":"American Joint Committee on Cancer","year":"1988","unstructured":"American Joint Committee on Cancer (1988) Manual for staging of cancer, 3rd edn. JB Lippincott Company, Philladelphia","edition":"3"},{"key":"9331_CR25","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1002\/cncr.20279","volume":"100","author":"PL Porter","year":"2004","unstructured":"Porter PL, Lund MJ, Lin MG et al (2004) Racial differences in expression of cell cycle regulatory proteins in breast cancer: study of young African American and white women in Atlanta. Cancer 100:2533\u20132542. doi: 10.1002\/cncr.20279","journal-title":"Cancer"},{"key":"9331_CR26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/path.1711680404","volume":"168","author":"G Cattoretti","year":"1992","unstructured":"Cattoretti G, Becker MH, Key G et al (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357\u2013363. doi: 10.1002\/path.1711680404","journal-title":"J Pathol"},{"key":"9331_CR27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.1711680114","volume":"168","author":"J Gerdes","year":"1992","unstructured":"Gerdes J, Becker MH, Key G, Cattoretti G (1992) Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues (see comment). J Pathol 168:85\u201386. doi: 10.1002\/path.1711680114","journal-title":"J Pathol"},{"key":"9331_CR28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","volume":"29","author":"SM Hsu","year":"1981","unstructured":"Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures (see comment). J Histochem Cytochem 29:577\u2013580","journal-title":"J Histochem Cytochem"},{"key":"9331_CR29","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1177\/30.10.6182185","volume":"30","author":"SM Hsu","year":"1982","unstructured":"Hsu SM, Soban E (1982) Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. J Histochem Cytochem 30:1079\u20131082","journal-title":"J Histochem Cytochem"},{"key":"9331_CR30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0046-8177(94)90198-8","volume":"25","author":"CR Taylor","year":"1994","unstructured":"Taylor CR, Shi SR, Chaiwun B, Young L, Imam SA, Cote RJ (1994) Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques (see comment). Hum Pathol 25:263\u2013270. doi: 10.1016\/0046-8177(94)90198-8","journal-title":"Hum Pathol"},{"key":"9331_CR31","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/1097-0142(19891101)64:9<1901::AID-CNCR2820640924>3.0.CO;2-W","volume":"64","author":"J Andersen","year":"1989","unstructured":"Andersen J, Poulsen HS (1989) Immunohistochemical estrogen receptor determination in paraffin-embedded tissue. Prediction of response to hormonal treatment in advanced breast cancer. Cancer 64:1901\u20131908. doi: 10.1002\/1097-0142(19891101)64:9<1901::AID-CNCR2820640924>3.0.CO;2-W","journal-title":"Cancer"},{"key":"9331_CR32","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0046-8177(88)80013-3","volume":"19","author":"FF Parl","year":"1988","unstructured":"Parl FF, Posey YF (1988) Discrepancies of the biochemical and immunohistochemical estrogen receptor assays in breast cancer. Hum Pathol 19:960\u2013966. doi: 10.1016\/S0046-8177(88)80013-3","journal-title":"Hum Pathol"},{"key":"9331_CR33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/jcp.43.3.239","volume":"43","author":"S Shousha","year":"1990","unstructured":"Shousha S, Stamp T, James K, Alaghband-Zadeh J (1990) Immunohistochemical study of oestrogen receptors in breast carcinomas that are biochemically receptor negative. J Clin Pathol 43:239\u2013242. doi: 10.1136\/jcp.43.3.239","journal-title":"J Clin Pathol"},{"key":"9331_CR34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/jcp.41.4.444","volume":"41","author":"D Giri","year":"1988","unstructured":"Giri D, Goepel J, Rogers K (1988) Immunohistological demonstration of progesterone receptor in breast carninomas: correlation with radioligand binding assays and oestrogen receptor negative. J Clin Pathol 41:444\u2013447. doi: 10.1136\/jcp.41.4.444","journal-title":"J Clin Pathol"},{"key":"9331_CR35","first-page":"2771","volume":"54","author":"MF Press","year":"1994","unstructured":"Press MF, Hung G, Godolphin W, Slamon DJ (1994) Sensitivity of HER-2\/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. Cancer Res 54:2771\u20132777","journal-title":"Cancer Res"},{"key":"9331_CR36","first-page":"1669","volume":"7","author":"P Birner","year":"2001","unstructured":"Birner P, Oberhuber G, Stani J et al (2001) Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. Clin Cancer Res 7:1669\u20131675","journal-title":"Clin Cancer Res"},{"key":"9331_CR37","first-page":"173","volume":"3","author":"CB Begg","year":"1994","unstructured":"Begg CB, Zhang ZF (1994) Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev 3:173\u2013175","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9331_CR38","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","volume":"14","author":"MC Cheang","year":"2008","unstructured":"Cheang MC, Voduc D, Bajdik C et al (2008) Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14:1368\u20131376. doi: 10.1158\/1078-0432.CCR-07-1658","journal-title":"Clin Cancer Res"},{"key":"9331_CR39","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1158\/1055-9965.EPI-06-0671","volume":"15","author":"SS Tworoger","year":"2006","unstructured":"Tworoger SS, Eliassen AH, Missmer SA et al (2006) Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women. Cancer Epidemiol Biomarkers Prev 15:2494\u20132501. doi: 10.1158\/1055-9965.EPI-06-0671","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9331_CR40","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/ijc.22812","volume":"121","author":"ME Sherman","year":"2007","unstructured":"Sherman ME, Rimm DL, Yang XR et al (2007) Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: a population-based analysis. Int J Cancer 121:1079\u20131085. doi: 10.1002\/ijc.22812","journal-title":"Int J Cancer"},{"key":"9331_CR41","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1158\/1055-9965.1558.13.10","volume":"13","author":"MD Althuis","year":"2004","unstructured":"Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 13:1558\u20131568","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9331_CR42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10549-006-9346-1","volume":"103","author":"KF Trivers","year":"2007","unstructured":"Trivers KF, Gammon MD, Abrahamson PE et al (2007) Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res Treat 103:93\u2013102. doi: 10.1007\/s10549-006-9346-1","journal-title":"Breast Cancer Res Treat"},{"key":"9331_CR43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/01.AOG.0000128173.01611.ff","volume":"104","author":"MK Whiteman","year":"2004","unstructured":"Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA (2004) Reproductive history and mortality after breast cancer diagnosis. Obstet Gynecol 104:146\u2013154","journal-title":"Obstet Gynecol"},{"issue":"8","key":"9331_CR44","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1158\/1055-9965.EPI-05-0106","volume":"14","author":"MK Whiteman","year":"2005","unstructured":"Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA (2005) Body mass and mortality after breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev 14(8):2009\u20132014. doi: 10.1158\/1055-9965.EPI-05-0106","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9331_CR45","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1158\/1055-9965.EPI-06-0356","volume":"15","author":"PE Abrahamson","year":"2006","unstructured":"Abrahamson PE, Gammon MD, Lund MJ et al (2006) General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiol Biomarkers Prev 15:1871\u20131877. doi: 10.1158\/1055-9965.EPI-06-0356","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"9331_CR46","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.pmed.0020124","volume":"2","author":"JP Ioannidis","year":"2005","unstructured":"Ioannidis JP (2005) Why most published research findings are false. PLoS Med 2(8):e124","journal-title":"PLoS Med"},{"key":"9331_CR47","volume-title":"SEER cancer statistics review, 1975\u20132004","author":"LAG Ries","year":"2006","unstructured":"Ries LAG, Melbert D, Krapcho M et al (2006) SEER cancer statistics review, 1975\u20132004. National Cancer Institute, Bethesda"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-009-9331-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-009-9331-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-009-9331-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T09:23:27Z","timestamp":1710235407000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-009-9331-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,3]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["9331"],"URL":"https:\/\/doi.org\/10.1007\/s10552-009-9331-1","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,3]]}}}